Company: TXG
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001770787-25-000013
Chunk: 125

Company: 10x Genomics, Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 5
Chunk 125
---
 each index at market close on September 12, 2019 (the first day of trading of our Class A Common Stock on the Nasdaq Global Select Market) and its relative performance is tracked through December 31, 2024. Pursuant to applicable Securities and Exchange Commission rules, all values assume reinvestment of the full amount of all dividends, however no dividends have been declared on our Class A common stock to date. The offering price of our Class A common stock in our initial public offering (“IPO”), which had a closing stock price of $52.75 on September 12, 2019, was $39.00 per share. The stockholder returns shown on the graph below are based on historical results and are not indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns.

60

Table of Contents

COMPARISON OF CUMULATIVE TOTAL RETURN

among 10x Genomics, Inc., the Nasdaq Composite Index, the Nasdaq Biotechnology Composite Index and the Russell 3000 Medical Equipment and Services Sector Index

Cumulative Total ReturnDecember 31, 2019December 31, 2020December 31, 2021December 31, 2022December 31, 2023December 31, 202410x Genomics, Inc.$100 $185.70 $195.36 $47.79 $73.39 $18.83 Nasdaq Composite Index100 143.64 174.36 116.65 167.30 215.22 Nasdaq Biotechnology Composite Index100 126.42 126.45 113.65 118.87 118.20 Russell 3000 Medical Equipment and Services Sector Index$100 $124.71 $150.60 $117.11 $122.95 $130.71 

Securities Authorized for Issuance under Equity Compensation Plans

The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2025 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after December 31, 2024.

Sales of Unregistered Securities

None.

Use of Proceeds

None.

Issuer Purchases of Equity Securities

None.